Fingerprint
Dive into the research topics of 'A phase i trial of pan-Bcl-2 antagonist obatoclax administered as a 3-h or a 24-h infusion in combination with carboplatin and etoposide in patients with extensive-stage small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically